FindTrial
Sign In

To explore the effective dose of hydromorphone in preventing early postoperative pain after laparoscopic hernia repair in children.

To explore the effective dose of hydromorphone in preventing early postoperative pain after laparoscopic hernia repair in children

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116860
Enrollment
Unknown
Registered
2026-01-15
Start date
2025-08-30
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

Experimental group:For pediatric patients undergoing surgery, routine anesthesia was administered. During the cessation of pneumoperitoneum, hydromorphone was used as the initial dose for analgesia at
conversely, if successful, the next patients dose was decreased by 0.5 µg/kg

Sponsors

The Sixth Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age: 1–6 years old; 2. ASA classification I or II; 3. BMI <= 30 kg/m^2; 4. Pediatric patients scheduled for elective laparoscopic hernia repair under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Allergic to the medications used in this study; 2. Recently had an upper respiratory tract infection; 3. Used sedatives or analgesics within 24 hours before surgery; 4. History of neurological, psychiatric, or cardiopulmonary diseases.

Design outcomes

Primary

MeasureTime frame
FLACC Pain Score;—

Secondary

MeasureTime frame
Blood pressure;Heart rate;Oxyhemoglobin saturation;the modified yale preoperative anxiety scale;pediatric anesthesia emergence delirium scale;—

Countries

China

Contacts

Public ContactYing He

The Sixth Affiliated Hospital of Harbin Medical University

13633646828@163.com+86 136 3364 6828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026